The aging heart and post-infarction left ventricular remodeling

Journal of the American College of Cardiology

Volumn 57, Issue 1, 2011, Pages 9-17

  Shih, Henry ^a   Lee, Brian ^a   Lee, Randall J ^a   Boyle, Andrew J ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

aging; left ventricular remodeling; myocardial infarction

Indexed keywords

ACETYLSALICYLIC ACID; ALDOSTERONE ANTAGONIST; ANTITHROMBOCYTIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; FIBRINOLYTIC AGENT; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;

AGE; AGED; AGING; APOPTOSIS; ARTICLE; AUTOPHAGY; CARDIOVASCULAR DISEASE; CELL DIVISION; CELL ORGANELLE; CELL RENEWAL; DRUG INDICATION; HEART FAILURE; HEART INFARCTION; HEART MUSCLE CELL; HEART VENTRICLE REMODELING; HUMAN; NONHUMAN; PATHOPHYSIOLOGY; PRACTICE GUIDELINE; PRIORITY JOURNAL; RISK FACTOR; SIGNAL TRANSDUCTION; STEM CELL; STRESS;

EID: 78650611093     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jacc.2010.08.623     Document Type: Review

References (85)

1. National Institutes of Health National Heart Lung and Blood Institute Factbook Fiscal Year 2008 http://www.nhlbi.nih.gov/about/factbook/FactBookFinal. pdf Accessed June 1, 2010
2. D. Lloyd-Jones, R.J. Adams, and T.M. Brown Heart disease and stroke statistics2010 update: a report from the American Heart Association Circulation 121 2010 e46 e215
3. Z.R. Yousef, S.R. Redwood, and M.S. Marber Postinfarction left ventricular remodelling: where are the theories and trials leading us? Heart 83 2000 76 80
4. Administration on Aging A Profile of Older Americans: 2008 Department of Health and Human Services http://www.csrees.usda.gov/nea/economics/pdfs/profile- older-american-2008.pdf Accessed June 1, 2010
5. National Heart, Lung, and Blood Institute Incidence and Prevalence: 2006 Chart Book on Cardiovascular and Lung Diseases 2006 National Institutes of Health Bethesda, MD
6. A.A. Maggioni, A. Maseri, and C. Fresco Age-related increase in mortality among patients with first myocardial infarctions treated with thrombolysis N Engl J Med 329 1993 1442 1448
7. J.P. Ornato, M.A. Peberdy, S.C. Tadler, and N.C. Strobos Factors associated with the occurrence of cardiac arrest during hospitalization for acute myocardial infarction in the second national registry of myocardial infarction in the US Resuscitation 48 2001 117 123
8. J.K. French, A.S. Hellkamp, and P.W. Armstrong Mechanical complications after percutaneous coronary intervention in ST-elevation myocardial infarction (from APEX-AMI) Am J Cardiol 105 2010 59 63
9. The GUSTO Investigators An international randomized trial comparing four thrombolytic strategies for acute myocardial infarction N Engl J Med 329 1993 673 682
10. Fibrinolytic Therapy Trialists' (FTT) Collaborative Group Indications for fibrinolytic therapy in suspected acute myocardial infarction: collaborative overview of early mortality and major morbidity results from all randomised trials of more than 1000 patients Lancet 343 1994 311 322
11. E.C. Keeley, J.A. Boura, and C.L. Grines Primary angioplasty versus intravenous thrombolytic therapy for acute myocardial infarction: a quantitative review of 23 randomised trials Lancet 361 2003 13 20
12. K.P. Alexander, L.K. Newby, and P.W. Armstrong Acute coronary care in the elderly, Part II: ST-segment-elevation myocardial infarction: a scientific statement for healthcare professionals from the American Heart Association Council on Clinical Cardiology: in collaboration with the Society of Geriatric Cardiology Circulation 115 2007 2570 2589
13. H.M. Krumholz, J.E. Murillo, and J. Chen Thrombolytic therapy for eligible elderly patients with acute myocardial infarction JAMA 277 1997 1683 1688
14. M. Singh, E.D. Peterson, and M.T. Roe Trends in the association between age and in-hospital mortality after percutaneous coronary intervention: National Cardiovascular Data Registry experience Circ Cardiovasc Interv 2 2009 20 26
15. A. de Labriolle, B. Giraudeau, and G. Pacouret Revascularization algorithm in acute STEMI should take into account age Cardiovasc Revasc Med 8 2007 90 93
16. P. Wenaweser, M. Ramser, and S. Windecker Outcome of elderly patients undergoing primary percutaneous coronary intervention for acute ST-elevation myocardial infarction Catheter Cardiovasc Interv 70 2007 485 490
17. M.-J. de Boer, J.-P. Ottervanger, A.W.J. van't Hof, J.C.A. Hoorntje, H. Suryapranata, and F. Zijlstra Reperfusion therapy in elderly patients with acute myocardial infarction: a randomized comparison of primary angioplasty and thrombolytic therapy J Am Coll Cardiol 39 2002 1723 1728
18. H.L. Dauerman, T.J. Ryan Jr., and W.D. Piper Outcomes of percutaneous coronary intervention among elderly patients in cardiogenic shock: a multicenter, decade-long experience J Invasive Cardiol 15 2003 380 384
19. V. Dzavik, L.A. Sleeper, and T.P. Cocke Early revascularization is associated with improved survival in elderly patients with acute myocardial infarction complicated by cardiogenic shock: a report from the SHOCK Trial Registry Eur Heart J 24 2003 828 837
20. D.E. Forman, and M.W. Rich Heart failure in the elderly Congest Heart Fail 9 2003 311 323
21. M. Spiecker Heart failure in elderly patients Exp Gerontol 41 2006 549 551
22. J.A. Ezekowitz, P. Kaul, J.A. Bakal, P.W. Armstrong, R.C. Welsh, and F.A. McAlister Declining in-hospital mortality and increasing heart failure incidence in elderly patients with first myocardial infarction J Am Coll Cardiol 53 2009 13 20
23. R.S. Velagaleti, M.J. Pencina, and J.M. Murabito Long-term trends in the incidence of heart failure after myocardial infarction Circulation 118 2008 2057 2062
24. K.E. Gould, G.E. Taffet, and L.H. Michael Heart failure and greater infarct expansion in middle-aged mice: a relevant model for postinfarction failure Am J Physiol Heart Circ Physiol 282 2002 H615 H621
25. M.C. Maiuri, E. Zalckvar, A. Kimchi, and G. Kroemer Self-eating and self-killing: crosstalk between autophagy and apoptosis Nat Rev Mol Cell Biol 8 2007 741 752
26. J. Sjostrom, and J. Bergh How apoptosis is regulated, and what goes wrong in cancer BMJ 322 2001 1538 1539
27. G. Olivetti, R. Abbi, and F. Quaini Apoptosis in the failing human heart N Engl J Med 336 1997 1131 1141
28. K. Hayakawa, G. Takemura, and M. Koda Sensitivity to apoptosis signal, clearance rate, and ultrastructure of fas ligand-induced apoptosis in in vivo adult cardiac cells Circulation 105 2002 3039 3045
29. T. Nakagawa, H. Zhu, and N. Morishima Caspase-12 mediates endoplasmic-reticulum-specific apoptosis and cytotoxicity by amyloid-[beta] Nature 403 2000 98 103
30. K.F. Ferri, and G. Kroemer Organelle-specific initiation of cell death pathways Nat Cell Biol 3 2001 E255 E263
31. L. Centurione, A. Antonucci, and S. Miscia Age-related death-survival balance in myocardium: an immunohistochemical and biochemical study Mech Ageing Dev 123 2002 341 350
32. T. Ozawa Mitochondrial DNA mutations and age Ann N Y Acad Sci 854 1998 128 154
33. S.J. Dubec, R. Aurora, and H.P. Zassenhaus Mitochondrial DNA mutations may contribute to aging via cell death caused by peptides that induce cytochrome c release Rejuvenation Res 11 2008 611 619
34. G. Olivetti, M. Melissari, J. Capasso, and P. Anversa Cardiomyopathy of the aging human heart Myocyte loss and reactive cellular hypertrophy Circ Res 68 1991 1560 1568
35. G. Azhar, L. Liu, X. Zhang, and J.Y. Wei Influence of age on hypoxia/reoxygenation-induced DNA fragmentation and Bcl-2, Bcl-xl, Bax and Fas in the rat heart and brain Mech Ageing Dev 112 1999 5 25
36. M. Pollack, S. Phaneuf, A. Dirks, and C. Leeuwenburgh The role of apoptosis in the normal aging brain, skeletal muscle, and heart Ann N Y Acad Sci 959 2002 93 107
37. M.T. Crow, K. Mani, Y.-J. Nam, and R.N. Kitsis The mitochondrial death pathway and cardiac myocyte apoptosis Circ Res 95 2004 957 970
38. R.J. Youle, and A. Strasser The BCL-2 protein family: opposing activities that mediate cell death Nat Rev Mol Cell Biol 9 2008 47 59
39. P. Meier, and K.H. Vousden Lucifer's labyrinthten years of path finding in cell death Mol Cell 28 2007 746 754
40. P.A. Henkart ICE family proteases: mediators of all apoptotic cell death? Immunity 4 1996 195 201
41. H. Sakahira, M. Enari, and S. Nagata Cleavage of CAD inhibitor in CAD activation and DNA degradation during apoptosis Nature 391 1998 96 99
42. G. Chen, and D.V. Goeddel TNF-R1 signaling: a beautiful pathway Science 296 2002 1634 1635
43. W. Chao, Y. Shen, L. Li, and A. Rosenzweig Importance of FADD signaling in serum deprivation- and hypoxia-induced cardiomyocyte apoptosis J Biol Chem 277 2002 31639 31645
44. A. Nakai, O. Yamaguchi, and T. Takeda The role of autophagy in cardiomyocytes in the basal state and in response to hemodynamic stress Nat Med 13 2007 619 624
45. Y. Matsui, H. Takagi, and X. Qu Distinct roles of autophagy in the heart during ischemia and reperfusion: roles of AMP-activated protein kinase and Beclin 1 in mediating autophagy Circ Res 100 2007 914 922
46. U.T. Brunk, and A. Terman The mitochondrial-lysosomal axis theory of aging Eur J Biochem 269 2002 1996 2002
47. A. Terman, H. Dalen, J.W. Eaton, J. Neuzil, and U.T. Brunk Mitochondrial recycling and aging of cardiac myocytes: the role of autophagocytosis Exp Gerontol 38 2003 863 876
48. P. Tannous, H. Zhu, and A. Nemchenko Intracellular protein aggregation is a proximal trigger of cardiomyocyte autophagy Circulation 117 2008 3070 3078
49. N.R. Brady, A. Hamacher-Brady, H. Yuan, and R.A. Gottlieb The autophagic response to nutrient deprivation in the hl-1 cardiac myocyte is modulated by Bcl-2 and sarco/endoplasmic reticulum calcium stores FEBS J 274 2007 3184 3197
50. Y.S. Rajawat, Z. Hilioti, and I. Bossis Aging: central role for autophagy and the lysosomal degradative system Ageing Res Rev 8 2009 199 213
51. K.R. Chien, and E.N. Olson Converging pathways and principles in heart development and disease Cell 110 2002 153 162
52. P. Gosse Left ventricular hypertrophy as a predictor of cardiovascular risk J Hypertens Suppl 23 2005 S27 S33
53. D. Susic, and E.D. Frohlich The aging hypertensive heart: a brief update Nat Clin Pract Cardiovasc Med 5 2008 104 110
54. D. Levy, R.J. Garrison, D.D. Savage, W.B. Kannel, and W.P. Castelli Prognostic implications of echocardiographically determined left ventricular mass in the Framingham Heart Study N Engl J Med 322 1990 1561 1566
55. P. Verdecchia, F. Angeli, L. Pittavini, R. Gattobigio, G. Benemio, and C. Porcellati Regression of left ventricular hypertrophy and cardiovascular risk changes in hypertensive patients Ital Heart J 5 2004 505 510
56. P. Razeghi, and H. Taegtmeyer Hypertrophy and atrophy of the heart Ann Nw Y Acad Sci 1080 2006 110 119
57. N. Frey, H.A. Katus, E.N. Olson, and J.A. Hill Hypertrophy of the heart: a new therapeutic target? Circulation 109 2004 1580 1589
58. J.R. McMullen, and G.L. Jennings Differences between pathological and physiological cardiac hypertrophy: novel therapeutic strategies to treat heart failure Clin Exp Pharmacol Physiol 34 2007 255 262
59. P. Anversa, T. Palackal, E. Sonnenblick, G. Olivetti, L. Meggs, and J. Capasso Myocyte cell loss and myocyte cellular hyperplasia in the hypertrophied aging rat heart Circ Res 67 1990 871 885
60. B. Nadal-Ginard, J. Kajstura, A. Leri, and P. Anversa Myocyte death, growth, and regeneration in cardiac hypertrophy and failure Circ Res 92 2003 139 150
61. A.P. Beltrami, K. Urbanek, and J. Kajstura Evidence that human cardiac myocytes divide after myocardial infarction N Engl J Med 344 2001 1750 1757
62. M.J.v. Amerongen, and F.B. Engel Features of cardiomyocyte proliferation and its potential for cardiac regeneration J Cell Mol Med 12 2008 2233 2244
63. J. Kajstura, A. Leri, N. Finato, C. Di Loreto, C.A. Beltrami, and P. Anversa Myocyte proliferation in end-stage cardiac failure in humans Proc Natl Acad Sci U S A 95 1998 8801 8805
64. J. Campisi, and F. d'Adda di Fagagna Cellular senescence: when bad things happen to good cells Nat Rev Mol Cell Biol 8 2007 729 740
65. P. Anversa, A. Leri, and J. Kajstura Cardiac regeneration J Am Coll Cardiol 47 2006 1769 1776
66. Y. Yeghiazarians, Y. Zhang, and M. Prasad Injection of bone marrow cell extract into infarcted hearts results in functional improvement comparable to intact cell therapy Mol Ther 17 2009 1250 1256
67. L.C. Amado, A.P. Saliaris, and K.H. Schuleri Cardiac repair with intramyocardial injection of allogeneic mesenchymal stem cells after myocardial infarction Proc Natl Acad Sci U S A 102 2005 11474 11479
68. A.D. Moelker, T. Baks, and K.M.A.M. Wever Intracoronary delivery of umbilical cord blood derived unrestricted somatic stem cells is not suitable to improve LV function after myocardial infarction in swine J Mol Cell Cardiol 42 2007 735 745
69. X. Bai, Y. Yan, and Y.H. Song Both cultured and freshly isolated adipose tissue-derived stem cells enhance cardiac function after acute myocardial infarction Eur Heart J 31 2010 394 397
70. A.J. Boyle, M. Schuster, and P. Witkowski Additive effects of endothelial progenitor cells combined with ACE inhibition and beta-blockade on left ventricular function following acute myocardial infarction J Renin Angiotensin Aldosterone Syst 6 2005 33 37
71. E. Messina, L. De Angelis, and G. Frati Isolation and expansion of adult cardiac stem cells from human and murine heart Circ Res 95 2004 911 921
72. D. Torella, M. Rota, and D. Nurzynska Cardiac stem cell and myocyte aging, heart failure, and insulin-like growth factor-1 overexpression Circ Res 94 2004 514 524
73. E.H. Blackburn Telomere states and cell fates Nature 408 2000 53 56
74. C. Chimenti, J. Kajstura, and D. Torella Senescence and death of primitive cells and myocytes lead to premature cardiac aging and heart failure Circ Res 93 2003 604 613
75. O. Bergmann, R.D. Bhardwaj, and S. Bernard Evidence for cardiomyocyte renewal in humans Science 324 2009 98 102
76. I. Banerjee, J.W. Fuseler, R.L. Price, T.K. Borg, and T.A. Baudino Determination of cell types and numbers during cardiac development in the neonatal and adult rat and mouse Am J Physiol Heart Circ Physiol 293 2007 H1883 H1891
77. M.L. Lindsey, D.K. Goshorn, and C.E. Squires Age-dependent changes in myocardial matrix metalloproteinase/tissue inhibitor of metalloproteinase profiles and fibroblast function Cardiovasc Res 66 2005 410 419
78. M. Bujak, H.J. Kweon, K. Chatila, N. Li, G. Taffet, and N.G. Frangogiannis Aging-related defects are associated with adverse cardiac remodeling in a mouse model of reperfused myocardial infarction J Am Coll Cardiol 51 2008 1384 1392
79. M.L. Burgess, J.C. McCrea, and H.L. Hedrick Age-associated changes in cardiac matrix and integrins Mech Ageing Dev 122 2001 1739 1756
80. P. Thomas, T. Cotter, X. Li, R. McCormick, and L. Gosselin Exercise training attenuates aging-associated increases in collagen and collagen crosslinking of the left but not the right ventricle in the rat Eur J Appl Physiol 85 2001 164 169
81. E.M. Antman, D.T. Anbe, and P.W. Armstrong ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarctionexecutive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 1999 Guidelines for the Management of Patients With Acute Myocardial Infarction) J Am Coll Cardiol 44 2004 671 719
82. F.G. Kushner, M. Hand, and S.C. Smith Jr. 2009 focused updates: ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction (updating the 2004 guideline and 2007 focused update) and ACC/AHA/SCAI guidelines on percutaneous coronary intervention (updating the 2005 guideline and 2007 focused update): a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines J Am Coll Cardiol 54 2009 2205 2241
83. I. Goldenberg, S. Matetzky, and A. Halkin Primary angioplasty with routine stenting compared with thrombolytic therapy in elderly patients with acute myocardial infarction Am Heart J 145 2003 862 867
84. J.S. Hochman, L.A. Sleeper, and J.G. Webb Early revascularization in acute myocardial infarction complicated by cardiogenic shock N Engl J Med 341 1999 625 634
85. S.D. Wiviott, E. Braunwald, and C.H. McCabe Intensive oral antiplatelet therapy for reduction of ischaemic events including stent thrombosis in patients with acute coronary syndromes treated with percutaneous coronary intervention and stenting in the TRITON-TIMI 38 trial: a subanalysis of a randomised trial Lancet 371 2008 1353 1363